Supplementary Table 2 from Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (&lt;sup&gt;213&lt;/sup&gt;Bi-DOTA-PESIN and &lt;sup&gt;213&lt;/sup&gt;Bi-AMBA versus&lt;sup&gt;177&lt;/sup&gt;Lu-DOTA-PESIN)